Use of macrolides and tetracyclines for chronic inflammatory diseases (Q35962028)

11 August 2017

1 reference

title

Use of macrolides and tetracyclines for chronic inflammatory diseases (English)

1 reference

11 August 2017

0 references

1 reference

Stacy A Voils

1

1 reference

11 August 2017

Martin E Evans

2

1 reference

11 August 2017

Matthew T Lane

3

1 reference

11 August 2017

Robert H Schosser

4

1 reference

11 August 2017

Robert P Rapp

5

1 reference

11 August 2017

language of work or name

English

0 references

publication date

23 November 2004

1 reference

Annals of Pharmacotherapy

11 August 2017

1 reference

11 August 2017

39

1 reference

11 August 2017

1

1 reference

11 August 2017

86-94

1 reference

Tetracycline therapy: update

11 August 2017

1 reference

Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense

21 January 2018

1 reference

Tularemia as a biological weapon: medical and public health management

21 January 2018

1 reference

Recognition and management of anthrax--an update

21 January 2018

1 reference

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

21 January 2018

1 reference

Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes

21 January 2018

1 reference

Use of antimicrobial agents and drug resistance

21 January 2018

1 reference

Anti-inflammatory effects of macrolides in lung disease

21 January 2018

1 reference

Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines

21 January 2018

1 reference

Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine

21 January 2018

1 reference

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

21 January 2018

1 reference

Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced cytokines and chemokines

21 January 2018

1 reference

Effects of Subantimicrobial-Dose Doxycycline in the Treatment of Moderate Acne

21 January 2018

1 reference

Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study

21 January 2018

1 reference

Minocycline effect on meibomian gland lipids in meibomianitis patients

21 January 2018

1 reference

Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea

21 January 2018

1 reference

Effects of minocycline on the ocular flora of patients with acne rosacea or seborrheic blepharitis.

21 January 2018

1 reference

The "cyclic" regimen of low-dose doxycycline for adult periodontitis: a preliminary study

21 January 2018

1 reference

The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis.

21 January 2018

1 reference

A double-blind placebo-controlled trial of azithromycin as an adjunct to non-surgical treatment of periodontitis in adults: clinical results

21 January 2018

1 reference

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

21 January 2018

1 reference

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

21 January 2018

1 reference

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

21 January 2018

1 reference

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

Secondary prevention antibiotic treatment trials for coronary artery disease

21 January 2018

1 reference

Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease

21 January 2018

1 reference

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction

21 January 2018

1 reference

Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study

21 January 2018

1 reference

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study

21 January 2018

1 reference

Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome

21 January 2018

1 reference

Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA).

21 January 2018

1 reference

Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial

21 January 2018

1 reference

Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial

21 January 2018

1 reference

Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors

21 January 2018

1 reference

Macrolide therapy for Chlamydia pneumoniae in the secondary prevention of coronary artery disease: a meta-analysis of randomized controlled trials.

21 January 2018

1 reference

Description and status of the azithromycin and coronary events study (ACES).

21 January 2018

1 reference

Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial

21 January 2018

1 reference

Guidelines for the management of rheumatoid arthritis: 2002 Update

21 January 2018

1 reference

Resistance of propionibacteria to antibiotics used in the treatment of acne

21 January 2018

1 reference

Changing Patterns of Plasmid-Mediated Drug Resistance During Tetracycline Therapy

21 January 2018

1 reference

Long-term use of subantimicrobial dose doxycycline does not lead to changes in antimicrobial susceptibility

21 January 2018

1 reference

High Rate of Macrolide Resistance inStaphylococcus aureusStrains from Patients with Cystic Fibrosis Reveals High Proportions of Hypermutable Strains

21 January 2018

1 reference

Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae

21 January 2018

1 reference

Antimicrobial resistance of invasive pneumococci in Finland in 1999-2000.

21 January 2018

1 reference

Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany

21 January 2018

1 reference

Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.

21 January 2018

1 reference

Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment

21 January 2018

1 reference

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

21 January 2018

1 reference

Macrolide resistance among invasive Streptococcus pneumoniae isolates

21 January 2018

1 reference

Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000.

21 January 2018

1 reference

Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States

21 January 2018

1 reference

Distribution of resistance genes tet(M), aph3'-III, catpC194 and the integrase gene of Tn1545 in clinical Streptococcus pneumoniae harbouring erm(B) and mef(A) genes in Spain

21 January 2018

1 reference

Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study

21 January 2018

1 reference

Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics.

21 January 2018

1 reference

The use of anti-inflammatory medications in cystic fibrosis: trends and physician attitudes

21 January 2018

1 reference

Effect of high-dose ibuprofen in patients with cystic fibrosis.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1E282

1 reference

11 August 2017

1 reference